Jubilant Life nears 52-week high, soars 41% in 8 days on strong Q4 results

Jubilant Life Sciences reported 92 per cent year on year (YoY) jump in normalised profit after tax at Rs 260 crore in Q4FY20. Ebitda margin also improved to 23.7 per cent from 16.3 per cent in Q4FY19.

Shares of Jubilant Life Sciences extended its seven-day rally and surged 12 per cent to Rs 625 on the BSE on Wednesday in the early morning deals after the company reported strong earnings for the quarter ended March 2020 (Q4FY20).

The stock of the pharmaceutical company was trading close to its 52-week high of Rs 639, touched on January 23, 2020. In the first eight trading days of June, the stock has zoomed 41 per cent as compared to 5 per cent rise in the S&P BSE Sensex.

Jubilant Life Sciences reported 92 per cent year on year (YoY) jump